Opportunity Information: Apply for RFA IP 11 010
Apply for RFA IP 11 010
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhanced Surveillance for New Vaccine Preventable Disease" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Jul 23, 2012 and posted on Jan 7, 2011.
- Applicants must submit their applications by Aug 7, 2012 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM Eastern Time. Note.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "Enhanced Surveillance for New Vaccine Preventable Disease" (Funding Opportunity Number RFA IP 11 010) is a discretionary health grant offered as a cooperative agreement. The main goal is to create and support a set of surveillance and evaluation sites that work together as a coordinated national network called the New Vaccine Surveillance Network (NVSN). Through this network, funded sites are expected to carry out both multi-site projects (designed and implemented in collaboration across the network) and site-specific projects (tailored to local capabilities and needs) to measure and explain the impact of new vaccines and vaccine-related policies on illnesses affecting children. The focus includes diseases that are already preventable through existing childhood immunizations as well as diseases that could become vaccine-preventable in the future if new vaccines are developed or introduced.
A central theme of the announcement is strengthening real-world, population-based surveillance so vaccine effectiveness and policy decisions can be evaluated using consistent methods across multiple locations. By funding a small number of sites to operate under a single network structure, CDC is aiming to generate comparable data that can detect changes in disease patterns over time, assess outcomes after vaccine introduction, and provide evidence that can guide immunization recommendations and program strategies. Because this is a cooperative agreement, recipients should expect substantial involvement from CDC in areas such as project coordination, standardization of surveillance approaches, and network-level planning, rather than operating as fully independent grantees.
The opportunity anticipated making about five awards. Award amounts were set with a floor of $400,000 and a ceiling of $1,000,000, with no cost sharing or matching required. Eligibility was listed as unrestricted, meaning a wide range of entity types could apply, subject to any additional eligibility details that may have been included in the full announcement text. The program is associated with CFDA number 93.185, listed under "Immunization Research, Demonstration, Public Information and Education" and "Training and Clinical Skills Improvement Projects," which signals that the work is expected to support immunization-related research and public health practice improvements tied to vaccines and vaccine policy.
Key administrative details emphasize strict electronic submission requirements. Applications had to be submitted through Grants.gov and validated in eRA Commons, and to be considered on time they needed to be error-free and available to CDC for processing by 5:00 PM Eastern Time on the deadline date. The notice highlights that CDC/HHS submission procedures do not include an error-correction window after the deadline; if the systems flagged errors or noncompliance after the due time, applicants would not have extra time to fix them. The opportunity was originally posted January 7, 2011, with an original closing date of April 5, 2011, and a later current closing date of August 7, 2012. The archive date was August 8, 2012.
For applicants or organizations needing help accessing the full announcement, the contact point listed is the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700, with a general email referenced in the notice.
FAQs: CDC Cooperative Agreement - Enhanced Surveillance for New Vaccine Preventable Disease (RFA IP 11 010)
What is the name of this CDC funding opportunity?
The opportunity is titled "Enhanced Surveillance for New Vaccine Preventable Disease" and is identified by Funding Opportunity Number RFA IP 11 010.
Which agency is offering this grant?
The funding opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
This is a discretionary health grant offered as a cooperative agreement, meaning funded recipients should expect substantial CDC involvement in key aspects of the work.
What is the main goal of the program?
The main goal is to create and support a set of surveillance and evaluation sites that work together as a coordinated national network called the New Vaccine Surveillance Network (NVSN).
What is the New Vaccine Surveillance Network (NVSN)?
NVSN is a coordinated national network of CDC-funded surveillance and evaluation sites intended to generate consistent, comparable data across multiple locations to measure and explain the impact of vaccines and vaccine-related policies on illnesses affecting children.
What kinds of projects are sites expected to conduct?
Funded sites are expected to conduct both:
- Multi-site projects designed and implemented collaboratively across the network, using consistent approaches across locations.
- Site-specific projects tailored to local capabilities and needs, while still supporting the overall network goals.
What populations or health outcomes are emphasized?
The focus is on illnesses affecting children and evaluating how new vaccines and vaccine-related policies impact disease outcomes.
What diseases are included in the program focus?
The focus includes diseases already preventable through existing childhood immunizations as well as diseases that could become vaccine-preventable in the future if new vaccines are developed or introduced.
Why does CDC emphasize population-based, real-world surveillance?
The announcement highlights strengthening real-world, population-based surveillance so vaccine effectiveness and policy decisions can be evaluated using consistent methods across multiple locations, helping detect changes in disease patterns over time and assess outcomes after vaccine introduction.
How many awards did CDC expect to make?
The opportunity anticipated making about five awards.
What is the expected award size?
Award amounts were set with a floor of $400,000 and a ceiling of $1,000,000.
Is cost sharing or matching required?
No. The opportunity states that no cost sharing or matching is required.
Who is eligible to apply?
Eligibility was listed as unrestricted, meaning a wide range of entity types could apply, subject to any additional eligibility details that may have been included in the full announcement text.
What CFDA number is associated with this program?
The program is associated with CFDA 93.185.
How is CFDA 93.185 described in the notice?
It is listed under "Immunization Research, Demonstration, Public Information and Education" and "Training and Clinical Skills Improvement Projects," indicating immunization-related research and public health practice improvements tied to vaccines and vaccine policy.
How does a cooperative agreement differ from a typical grant in this announcement?
The notice emphasizes that, because this is a cooperative agreement, recipients should expect substantial involvement from CDC in areas such as project coordination, standardization of surveillance approaches, and network-level planning, rather than operating as fully independent grantees.
What submission systems are required for applications?
Applications had to be submitted through Grants.gov and validated in eRA Commons.
What does it mean that the application must be "validated" in eRA Commons?
The notice indicates that submitting through Grants.gov is not the only step; the application also needs to be validated in eRA Commons so it can be available to CDC for processing by the deadline time.
What is the deadline time requirement mentioned in the announcement?
To be considered on time, applications needed to be error-free and available to CDC for processing by 5:00 PM Eastern Time on the deadline date.
Is there an error-correction window after the deadline?
No. The notice explicitly states that CDC/HHS submission procedures do not include an error-correction window after the deadline. If submission systems flag errors or noncompliance after the due time, applicants would not have extra time to fix them.
What were the key posting and closing dates?
The opportunity was originally posted on January 7, 2011. The original closing date was April 5, 2011, and a later current closing date was August 7, 2012.
When was this funding opportunity archived?
The archive date listed in the notice is August 8, 2012.
Who should applicants contact for help accessing the full announcement?
The contact point listed is the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
What contact details are provided in the notice?
The notice lists a phone number for the CDC PGO TIMS: 770-488-2700, and references a general email address in the notice.
Browse more opportunities from the same category: Health
Next opportunity: Affordable Care Act Health Center Planning Grants
Previous opportunity: Genomic Resource Grants for Community Resource Projects (U41)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 11 010
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 11 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Affordable Care Act Health Center Planning Grants Apply for HRSA 11 021 Funding Number: HRSA 11 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States Apply for RFA IP 11 003 Funding Number: RFA IP 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $785,000 |
| Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools. Apply for RFA IP 11 006 Funding Number: RFA IP 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Economic Studies of Vaccines and Immunization Policies, Programs and Practices Apply for RFA IP 11 007 Funding Number: RFA IP 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Incidence and Etiology of Influenza Associated Community Acquired Pneumonia in Hospitalized Persons Study Apply for RFA IP 11 011 Funding Number: RFA IP 11 011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH11 1105 Funding Number: CDC RFA EH11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Service Area Competition Additional Areas Apply for HRSA 11 163 Funding Number: HRSA 11 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Delta Health Initiative Apply for HRSA 11 090 Funding Number: HRSA 11 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition A Consortium to Study Genetics of Longevity (U19) Apply for PAR 11 101 Funding Number: PAR 11 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| EIS Ongoing Expansion Funds for Current Part C Grantees Apply for HRSA 11 092 Funding Number: HRSA 11 092 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| Ethiopia Comprehensive HIV AIDS Treatement Care and Support Program Apply for RFA 663 11 000005 Funding Number: RFA 663 11 000005 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $42,000,000 |
| Pediatric Device Consortia Grant Program (P50) Apply for RFA FD 11 002 Funding Number: RFA FD 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Programs to Improve the Health and Educational Outcomes of Young People Apply for CDC RFA DP11 1101 Funding Number: CDC RFA DP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Implementation of Programs to Improve Quality Laboratory Services in support of HIV/AIDS Care, Support and Treatment at the University Teaching Hospital Antiretroviral Clinic and Laboratory in the Republic of Zambia under PEPFAR Apply for CDC RFA GH11 1121 Funding Number: CDC RFA GH11 1121 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the National Reference Laboratory to Perform and Oversee Laboratory Services in Rwanda under the President s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Initiative Apply for CDC RFA GH11 1163 Funding Number: CDC RFA GH11 1163 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Free Communities Support Program Apply for SP 11 002 Funding Number: SP 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Capacity Building and Sustainability to Strengthen the Epidemiology and Laboratory Management Public Health Infrastructure of the Republic of Angola Apply for CDC RFA GH11 1186 Funding Number: CDC RFA GH11 1186 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH) (U01) Apply for RFA GH 11 002 Funding Number: RFA GH 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition for State Planning and Establishment Grants for the Affordable Care Acts Exchanges Apply for IE HBE 11 002 Funding Number: IE HBE 11 002 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: $1,000,000 |
| Development, Maintenance and Enhancement of Early Hearing Detection and Intervention Information System (EHDI IS) Surveillance Programs Apply for CDC RFA DD11 1101 Funding Number: CDC RFA DD11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $175,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 11 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.